Secretary of State John Kerry to press India to reverse government actions they said threaten millions of U.S. jobs in pharmaceutical, information technology and creative industries.» Read More
Time to begin picking through the rubble, looking for stocks that have already been crushed, Cramer said.
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.
Peter Wilmshurst, Portfolio Manager, Templeton Global Equity Group at Franklin Templeton Investments tells CNBC's Cash Flow why he likes pharmaceutical stocks at the moment.
The health-care industry is looking to harness big data, but finding the right workers isn't always easy. In some cases, companies are making acquisitions to bring talent in-house.
A team of oncologists from Sloan-Kettering have been working with IBM's Watson programmers and engineers to train the system to understand cancer treatment in the hopes of providing better care.
John Sculley, Former Apple CEO, Former PepsiCo President, and Partner at Sculley Brothers says Apple is still a strong player in the tech arena. He also sheds light on what could be the next big innovation from the technology and healthcare space.
Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.
*Remote monitoring not seen as cost effective in UK study. LONDON, March 22- Monitoring patients at home using modern technology, so-called' telehealth', is tipped as the next big thing in healthcare, but a new study by British researchers suggests it may not be worth the extra expense.
In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.
*Exchanges scheduled to be up and running on Jan. 1, 2014. WASHINGTON, March 14- The U.S. government could have to run more state health insurance exchanges than expected under President Barack Obama's healthcare law, if U.S. states pursuing their own marketplaces cannot complete them on time, a senior official said on Thursday.
LEUVEN, Belgium, March 6- 3 D printing has already changed the game for manufacturing specialised products such as medical devices but the real revolution will come when designers start to rethink the shapes of objects.
Irish drugmaker Elan has sweetened the terms on offer to shareholders under its $3.25 billion disposal plan, as it aims to stave off an approach for the company from U.S. investment firm Royalty Pharma.
A sharp and surprisingly persistent slowdown in the growth of health care costs is helping to narrow the federal deficit, leaving budget experts trying to figure out whether the trend will last.
Pfizer's unit Zoetis plans to sell 86.1 million shares at between $22 and $25 each in an initial public offering.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
States are setting up health insurance exchanges, reports CNBC's Bertha Coombs. Max Nisen, Business Insider, also weighs in.
It's hard to see how lawmakers can avoid touching health insurance if they want to eliminate loopholes and curtail deductions so as to raise revenue and lower tax rates.